Powder: -20°C for 3 years | In solvent: -80°C for 1 year
BMS 195614 (BMS614) is a selective RARα antagonist. BMS 195614 can bind to the RARα subunit.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 181.00 | |
5 mg | In stock | $ 418.00 | |
10 mg | In stock | $ 619.00 | |
25 mg | In stock | $ 988.00 | |
50 mg | In stock | $ 1,330.00 | |
100 mg | In stock | $ 1,780.00 | |
500 mg | In stock | $ 3,580.00 |
Description | BMS 195614 (BMS614) is a selective RARα antagonist. BMS 195614 can bind to the RARα subunit. |
In vitro | BMS 195614 reversed the induction effect of selective RARα agonists, AM580, AM80 and BMS 194753 on differentiation of the acute promyelocytic leukemia cell lines, NB4 and HL60 [1]. Treatment with retinoic acid (RA) (1 uM) for 72 hrs significantly reduced T47D breast cancer cells migration. But RA in combination with BMS 195614 did not affect the cell movement [2]. In cells of a bovine stromal-vascular fraction from intramuscular fat, BMS 195614 significantly diminished the anti-adipogenic effect of ATRA [3]. |
In vivo | BMS 195614 displayed poor in vivo activity in mice when administered orally. Treatment with BMS 195614 at oral doses for 1 month showed no inhibition to spermatogenesis [4]. Oral administration of BMS 195614 did not suppress spermatogenesis in mice [5]. |
Synonyms | BMS614 |
Molecular Weight | 448.51 |
Formula | C29H24N2O3 |
CAS No. | 253310-42-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 10.1 mg/mL (22.5 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMS 195614 253310-42-8 Metabolism Retinoid Receptor BMS-614 BMS195614 BMS 614 BMS614 BMS-195614 inhibitor inhibit